CLINICAL-APPLICATIONS OF SERUM MARKERS FOR LUNG-CANCER

被引：36

作者：

FERRIGNO, D

BUCCHERI, G

机构：

[1] Department of Respiratory Medicine, A. Carle Hospital, Cuneo

来源：

RESPIRATORY MEDICINE | 1995年 / 89卷 / 09期

关键词：

D O I：

10.1016/0954-6111(95)90225-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：587 / 597

页数：11

共 175 条

[81]

2-X

[82]

JAQUES G, 1993, CANCER, V72, P418, DOI 10.1002/1097-0142(19930715)72:2<418::AID-CNCR2820720217>3.0.CO

[83]

2-Q

[84]

JOHNSON DH, 1984, CANCER RES, V44, P5409

[85] TUMOR-MARKERS FOR PREDICTION OF SURVIVAL AND MONITORING OF REMISSION IN SMALL-CELL LUNG-CANCER [J].

JOHNSON, PWM ;

JOEL, SP ;

LOVE, S ;

BUTCHER, M ;

PANDIAN, MR ;

SQUIRES, L ;

WRIGLEY, PFM ;

SLEVIN, ML .

BRITISH JOURNAL OF CANCER, 1993, 67 (04) :760-766

[86] OCCURRENCE OF NEURON SPECIFIC ENOLASE IN TUMOR-TISSUE AND SERUM IN SMALL-CELL LUNG-CANCER [J].

JORGENSEN, LGM ;

HIRSCH, FR ;

SKOV, BG ;

OSTERLIND, K ;

COOPER, EH ;

LARSSON, LI .

BRITISH JOURNAL OF CANCER, 1991, 63 (01) :151-153

[87]

JORGENSEN LGM, 1987, EUR J CANCER CLIN ON, V1, P123

[88]

KATO H, 1984, CANCER, V54, P1544, DOI 10.1002/1097-0142(19841015)54:8<1544::AID-CNCR2820540813>3.0.CO

[89]

2-B

[90]

KATO H, 1977, CANCER, V40, P1621, DOI 10.1002/1097-0142(197710)40:4<1621::AID-CNCR2820400435>3.0.CO

← 4 5 6 7 8 9 10 11 12 13 →